Jason Assad

Jason Assad has a diverse work experience spanning across various industries. Jason has served as the President of C&H Capital Inc., where they provided seed financing and strategic advisory services to early-stage micro/small-cap companies. Jason has also held roles as the Director of Corporate Communications at TeraWulf and Unrivaled Brands, where they focused on managing corporate communications and branding strategies within the cannabis sector. Additionally, they have worked as the Head of Corporate Communications at Crown Electrokinetics, Gain Therapeutics, and 180 Life Sciences, leading the development and implementation of communication strategies in the biotechnology industry. Furthermore, Jason has served as a Communications Strategist at Coya Therapeutics and Processa Pharmaceuticals, leveraging their expertise in driving effective communication efforts for clinical-stage biotechnology companies. Prior to their roles in the biotech industry, they held the position of Head of Investor Relations at Hoth Therapeutics. Jason's professional experience also includes the role of Head of Corporate Communications at Amergent Hospitality Group, Inc. Overall, their work experience reflects a strong background in corporate communications, investor relations, and strategic advisory roles within various industries.

Jason Assad earned their Bachelor's Degree in Public Relations from The University of Georgia, graduating in 1993.